Related Experiment Video
Updated: Aug 1, 2026

10:59
Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury
Published on: November 19, 2012
15.8K
Ferroptosis-Mediated Hippocampal Neuronal Loss Post-mTBI: Chromatin Accessibility Profiling and Single-Nucleus
Manrui Li1, Qiuyun Yang2, Shengqiu Qu1
1Department of Forensic Genetics, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, 610041, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|December 15, 2025
Summary
Mild traumatic brain injury (mTBI) causes neuronal death via ferroptosis, a process linked to cognitive decline. The gene Tmsb4x shows potential for treating mTBI-induced cognitive dysfunction.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neuronal death in the hippocampus after mild traumatic brain injury (mTBI) contributes to cognitive dysfunction.
- The molecular mechanisms driving this neuronal death are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms of neuronal death following mTBI at single-cell resolution.
- To identify potential therapeutic targets for mitigating mTBI-induced cognitive deficits.
Main Methods:
- Single-nucleus RNA sequencing (snRNA-seq) and ATAC sequencing (snATAC-seq) were performed on the hippocampus of mTBI mice.
- Gene set enrichment analysis was used to identify active cell-death pathways.
- Transcription factor binding and gene regulation were analyzed.
Main Results:
- Ferroptosis was identified as the dominant cell-death pathway in hippocampal neurons after mTBI.
- Decreased binding of c-Jun and Rfx3 transcription factors was observed in dentate granule cells.
- The c-Jun-regulated gene Tmsb4x demonstrated neuroprotective effects, counteracted ferroptosis, and improved cognitive function in mice.
Conclusions:
- Ferroptosis is a critical mechanism underlying neuronal death and cognitive dysfunction after mTBI.
- Tmsb4x represents a promising therapeutic target for treating mTBI-related cognitive impairments.

